{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "will $amgn &amp; #sandoz court battle over 'patent-dance' when marketing a new #biosimilar drug set a new precedent? URL"}
{"text": "cowen &amp; co. sticks to its buy rating for amgen inc $amgn URL"}
{"text": "review amgen's q1 earnings deck.| URL $amgn AT_USER URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "enbrel sales fell 15% yoy while neulasta became $amgn's top earner URL"}
{"text": "rt AT_USER added to $csco $trow and started a position in $amgn today #dividends #dividend"}
{"text": "rt AT_USER $amgn and $gild are both quite cheap, current valuation is way below historical average #stocks #biotech #investing URL"}
{"text": "added to $csco $trow and started a position in $amgn today #dividends #dividend"}
{"text": "$amgn and $gild are both quite cheap, current valuation is way below historical average #stocks #biotech #investing URL"}
{"text": "AT_USER stopped out of $aks $amgn today"}
{"text": "rt AT_USER $amgn enbrel was approved ~20yrs ago, with $80b+ accumulated sales.  it's time to make room for new innovations as the sys\u00a1\u00ad"}
{"text": "what drove amgen's slight revenue fall in 1q17? URL $amgn $regn $celg $gild"}
{"text": "2017's first-quarter reports, with the newest from $bmy, $azn, $abbv, $amgn, $biib, $lly, $jnj, $gsk &amp; more URL"}
{"text": "losing faith in gilead sciences? here's an excellent alternative trading at a 24% discount ... URL $gild $amgn"}
{"text": "follow #nasdaq 100 traders &amp; track their tweets under one watchlist $amgn $qcom URL URL"}
{"text": "rt AT_USER on the fly: what to watch in biotech earnings reports $biib $amgn $celg $gild $ions URL"}
{"text": "going into close with $amgn ss $162.41 and $aaoi long from $47.75. #iceman #ita"}
{"text": "$amgn maturity 04/28/2017 vol putcallratio of 1.38 puts=4,979 calls=3,595 . URL URL"}
{"text": "on the fly: what to watch in biotech earnings reports $biib $amgn $celg $gild $ions URL"}
{"text": "#privatetrader #live #outcomes #entry $cvx $expe $gm $intc $msft $sbux #exit $amgn $dal URL"}
{"text": "was a nice buy at $159 for the roth.  could recovery off those lows $amgn URL"}
{"text": "$amgn #options volume chart in animation. free stock station app URL URL"}
{"text": "losing faith in gilead sciences? here's an excellent alternative trading at a 24% discount ... URL $gild $amgn"}
{"text": "rt AT_USER #pharma companies battle for slice of humira's billions. #fda #biosimilars $abbv $amgn $celg $jnj URL URL"}
{"text": "$amgn getting a lot of social media attention URL #womenshistorymonth #machinelearning URL"}
{"text": "$amgn 180 calls selling activity expiring on 19th jan, vol 1891"}
{"text": "stock traders buy high volume of call options on amgen $amgn URL"}
{"text": "$amgn took the down move well &amp; $ibb seems ok as long as 50ma holds\u00a1\u00ad impressive strength."}
{"text": "rt AT_USER AT_USER AT_USER $amgn in a contest to transform from drug company to a patent trolling company?"}
{"text": "amgn top news - apr 27th, 2017 $amgn URL"}
{"text": "$amgn post earnings low 160 and now reclaimed the 200dma...."}
{"text": "AT_USER more than likely- ophthalmic therapeutic inserts come &amp; go- quickly- pilosert was one\u00a1\u00ad URL"}
{"text": "$alxn make that 2/2 today. let's see if we can nail one more today. $amgn looks interesting, but a bit to overextended for my taste."}
{"text": "$agn $amgn still holding wkly levels"}
{"text": "$amgn: amgen uk's nice publishes final appraisal determination recommending blincyto as an option for treating... URL"}
{"text": "amgen's q1 results showed some weakness URL $amgn"}
{"text": "rt AT_USER cs - $amgn commentary re greater than expected weakness in rx for rheumatology/derm last night and $celg similar in slides -\u00a1\u00ad"}
{"text": "#amgen reports first quarter 2017 financial results  . read more: URL $amgn"}
{"text": "amgen's q1 results showed some weakness URL $amgn"}
{"text": "amgen's q1 results showed some weakness URL $amgn"}
{"text": "here are the top 25 autoimmune brands in 2016, based on u.s. #pharma sales. $abbv $amgn $jnj $ucb $bmy $pfe $celg\u00a1\u00ad URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "stock traders buy high volume of call options on amgen $amgn URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "losing faith in gilead sciences? here's an excellent alternative trading at a 24% discount ... URL $gild $amgn"}
{"text": "#amgen, sandoz argue biosimilar patent case to the supreme court. read more: URL $amgn"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "amgen misses on earnings. get the earnings deck here.| URL $amgn AT_USER"}
{"text": "#pharma companies battle for slice of humira's billions. #fda #biosimilars $abbv $amgn $celg $jnj\u00a1\u00ad URL"}
{"text": "#options #maxpain chart for $amgn. free options app URL URL"}
{"text": "$amgn optimistic despite sales saying otherwise URL"}
{"text": "$amgn optimistic despite sales saying otherwise URL"}
{"text": "rt AT_USER $amgn execs talk q1 sales dip, migraines and biosimilars, by AT_USER URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "$amgn execs talk q1 sales dip, migraines and biosimilars, by AT_USER URL"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "rt AT_USER balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply to $md\u00a1\u00ad"}
{"text": "balanced take on rnai approach in current drug development landscape by $amgn's sean harper, this should also apply\u00a1\u00ad URL"}
{"text": "$amgn #options oi chart. free stocks app URL URL"}
{"text": "#amgen's q1 results highlight the need for an acquisition. read more: URL $amgn"}
{"text": "trending on #stocktwits $amgn at URL #nes #digitalmarketing"}
{"text": "$amgn looks interesting"}
{"text": "$amgn #options volume chart in animation. free stock station app URL URL"}
{"text": "rt AT_USER amgen's q1 results highlight the need for an acquisition #earnings $amgn URL"}
{"text": "rt AT_USER $xbi over $ibb is mainly $exas. large cap outperformance is despite $amgn, $regn, $celg"}
{"text": "rt AT_USER years behind $amgn, $regn, alnylam/medicines co dive into ph3 + 14k-person outcome study w/inclisiran. URL"}
{"text": "amgen's q1 results highlight the need for an acquisition #earnings $amgn URL"}
{"text": "$celg $amgn completely diverged that move down in the s/p."}
{"text": "losing faith in gilead sciences? here's an excellent alternative trading at a 24% discount ... URL $gild $amgn"}
{"text": "rt AT_USER wall street breakfast: markets prepare for ecb meeting URL $spy $qqq $aal $amgn $antm $azn $ba $bab\u00a1\u00ad"}
{"text": "why amgn is down thursday URL $amgn"}
{"text": "rt AT_USER AT_USER AT_USER $amgn in a contest to transform from drug company to a patent trolling company?"}
{"text": "$amgn amgen uk's nice publishes final appraisal determination recommending blincyto as an option for treating adu\u00a1\u00ad URL"}
{"text": "$amgn great example of a gap down and retracement to the 20 ema URL"}
{"text": "rt AT_USER humira sales were $2.7b, up22%- not having the same problems that enbrel is apparently $abbv $amgn"}
{"text": "$amgn:us amgen reports mixed financials results as its lead drug, enbrel, sees sales decrease #amgen inc  URL #nasdaq"}
{"text": "AT_USER AT_USER $amgn in a contest to transform from drug company to a patent trolling company?"}
{"text": "$xbi over $ibb is mainly $exas. large cap outperformance is despite $amgn, $regn, $celg"}
{"text": "$amgn needs to hold 160 level several gaps below"}
{"text": "the top 9 overseas #biopharma accounts hold $133b in m&amp;a firepower $amgn $gild $mrk $pfe $lly $bmy $celg $biib $abbv URL"}
{"text": "rt AT_USER $amgn enbrel was approved ~20yrs ago, with $80b+ accumulated sales.  it's time to make room for new innovations as the sys\u00a1\u00ad"}
{"text": "amgen, inc. $amgn receives average rating of \u00a1\u00b0buy\u00a1\u00b1 from analysts URL"}
{"text": "$amgn beat eps forecasts by 14 cents (3.15 vs 3.01) on weaker revenues; reaffirmed guidance."}
{"text": "rt AT_USER wall street breakfast: markets prepare for #ecb meeting -- URL $spy $qqq $aal $amgn $antm $azn $pg #bu\u00a1\u00ad"}
{"text": "salphatrending: wall street breakfast: markets prepare for ecb meeting URL $spy $qqq $aal $amgn $antm $azn $ba $baba $\u00a1\u00ad"}
{"text": "wall street breakfast: markets prepare for ecb meeting URL $spy $qqq $aal $amgn $antm $azn $ba $baba $bcs $dal $db"}
{"text": "$amgn \"trade idea 3: buy the april 28 expiry 162.5/160 1\u00a1\u00e12 put spread for 10 cents.\" stc a 162.5/160 ps watch remaining 160"}
{"text": "a lot going on this morning. from #smbscanner. $exas $uaa $wtw $pypl $amgn URL"}
{"text": "$amgn \"trade idea 2: buy apr 28 expiry/may 170 call calendar &amp; sell apr 160 put for 20 cents.\" watch 160 puts, may need to roll down &amp; out"}
{"text": "biopharma shares moving after earnings: $bmy +3.2%, $abbv +1.3%, $alxn +3.5%, $celg -1.9%, $amgn -2.8%"}
{"text": "wall street breakfast: markets prepare for ecb meeting URL $spy $qqq $aal $amgn $antm $azn $ba $baba $bcs $dal $db"}
{"text": "wall street breakfast: markets prepare for #ecb meeting -- URL $spy $qqq $aal $amgn $antm $azn $pg #business #markets"}
{"text": "favs: $intu over 123.50, $alxn over 126, $bmy over 55.80, $exas over 28.50, $isle under 23, $amgn under 159!"}
{"text": "$amgn i thought i heard cramer talk about amgen yesterday but i wasn't really paying attention. did he recommend it yesterday?"}
